Together, these results show that tumor cell‐derived as well as microenvironment‐derived Apelin contributes to cancer progression through stimulation of tumor angiogenesis, enhancing vessel leakiness and tumor hypoxia, and altered infiltration of immune cells. This evidence concerns the gene APLN and cancer.